Optimal Timing of Resumption of Anticoagulation After ICH in Patients with Mechanical Heart Valves
23:48
Optimal Timing of Resumption of Anticoagulation After ICH in Patients with Mechanical Heart Valves
14 сағат бұрын
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage: The ANNEXA-I Trial
24:17
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage: The ANNEXA-I Trial
16 сағат бұрын
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage: The ANNEXA-I Trial
24:17
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage: The ANNEXA-I Trial
16 сағат бұрын
Comparison of Nebulized Ketamine to Intravenous Ketamine for Treating Acute Pain in the ED
15:06
Comparison of Nebulized Ketamine to Intravenous Ketamine for Treating Acute Pain in the ED
14 күн бұрын
Comparison of Nebulized Ketamine to Intravenous Ketamine for Treating Acute Pain in the ED
15:06
Comparison of Nebulized Ketamine to Intravenous Ketamine for Treating Acute Pain in the ED
14 күн бұрын
Methylene Blue Versus Hydroxocobalamin for Vasoplegic Shock
20:20
Methylene Blue Versus Hydroxocobalamin for Vasoplegic Shock
21 күн бұрын
Methylene Blue Versus Hydroxocobalamin for Vasoplegic Shock
20:20
Methylene Blue Versus Hydroxocobalamin for Vasoplegic Shock
21 күн бұрын
Diagnostic Stewardship in Community-Acquired Pneumonia with Syndromic Molecular Testing
21:30
Diagnostic Stewardship in Community-Acquired Pneumonia with Syndromic Molecular Testing
28 күн бұрын
Diagnostic Stewardship in Community-Acquired Pneumonia with Syndromic Molecular Testing
21:30
Diagnostic Stewardship in Community-Acquired Pneumonia with Syndromic Molecular Testing
28 күн бұрын
Ceftriaxone to Prevent Ventilator-Associated Pneumonia in Acute Brain Injury: The PROPHY-VAP Trial
18:58
Ceftriaxone to Prevent Ventilator-Associated Pneumonia in Acute Brain Injury: The PROPHY-VAP Trial
Ай бұрын
Ceftriaxone to Prevent Ventilator-Associated Pneumonia in Acute Brain Injury: The PROPHY-VAP Trial
18:58
Ceftriaxone to Prevent Ventilator-Associated Pneumonia in Acute Brain Injury: The PROPHY-VAP Trial
Ай бұрын
Risk of Bleeding Following DOAC Use in Patients with Acute Ischemic Stroke Treated with Alteplase
22:58
Risk of Bleeding Following DOAC Use in Patients with Acute Ischemic Stroke Treated with Alteplase
Ай бұрын
Risk of Bleeding Following DOAC Use in Patients with Acute Ischemic Stroke Treated with Alteplase
22:58
Risk of Bleeding Following DOAC Use in Patients with Acute Ischemic Stroke Treated with Alteplase
Ай бұрын
Effect of Intravenous Push and Piggyback Administration of Ceftriaxone on Mortality in Sepsis
19:40
Effect of Intravenous Push and Piggyback Administration of Ceftriaxone on Mortality in Sepsis
Ай бұрын
Effect of Intravenous Push and Piggyback Administration of Ceftriaxone on Mortality in Sepsis
19:40
Effect of Intravenous Push and Piggyback Administration of Ceftriaxone on Mortality in Sepsis
Ай бұрын
Antipsychotics and the QTc Interval During Delirium in the ICU
14:52
Antipsychotics and the QTc Interval During Delirium in the ICU
Ай бұрын
Antipsychotics and the QTc Interval During Delirium in the ICU
14:52
Antipsychotics and the QTc Interval During Delirium in the ICU
Ай бұрын
Ketamine vs Morphine for Out-of-Hospital Analgesia in Traumatic Pain: The KETAMORPH Study
19:39
Ketamine vs Morphine for Out-of-Hospital Analgesia in Traumatic Pain: The KETAMORPH Study
2 ай бұрын
Ketamine vs Morphine for Out-of-Hospital Analgesia in Traumatic Pain: The KETAMORPH Study
19:39
Ketamine vs Morphine for Out-of-Hospital Analgesia in Traumatic Pain: The KETAMORPH Study
2 ай бұрын
Time is Critical - Anticoagulation Reversal Time After Intracerebral Hemorrhage
23:03
Time is Critical - Anticoagulation Reversal Time After Intracerebral Hemorrhage
2 ай бұрын
Time is Critical - Anticoagulation Reversal Time After Intracerebral Hemorrhage
23:03
Time is Critical - Anticoagulation Reversal Time After Intracerebral Hemorrhage
2 ай бұрын
Four-Factor PCC vs Andexanet Alfa for the Reversal of DOACs In Traumatic Brain Injuries
17:42
Four-Factor PCC vs Andexanet Alfa for the Reversal of DOACs In Traumatic Brain Injuries
2 ай бұрын
Four-Factor PCC vs Andexanet Alfa for the Reversal of DOACs In Traumatic Brain Injuries
17:42
Four-Factor PCC vs Andexanet Alfa for the Reversal of DOACs In Traumatic Brain Injuries
2 ай бұрын
Tranexamic Acid for Angiotensin Converting Enzyme Inhibitor (ACE) Induced Angioedema
24:16
Tranexamic Acid for Angiotensin Converting Enzyme Inhibitor (ACE) Induced Angioedema
2 ай бұрын
Tranexamic Acid for Angiotensin Converting Enzyme Inhibitor (ACE) Induced Angioedema
24:16
Tranexamic Acid for Angiotensin Converting Enzyme Inhibitor (ACE) Induced Angioedema
2 ай бұрын
Argatroban in Patients With Acute Ischemic Stroke With Early Neurological Deterioration
19:05
Argatroban in Patients With Acute Ischemic Stroke With Early Neurological Deterioration
3 ай бұрын
Argatroban in Patients With Acute Ischemic Stroke With Early Neurological Deterioration
19:05
Argatroban in Patients With Acute Ischemic Stroke With Early Neurological Deterioration
3 ай бұрын
Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection
19:23
Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection
3 ай бұрын
Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection
19:23
Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection
3 ай бұрын
Пікірлер
@TE-7302-
@TE-7302- Ай бұрын
Those who have taken AS PRESCRIBED for years are the people who need help tapering off these horrendous drugs. What a waste of research money.
@scottmihalovic529
@scottmihalovic529 4 ай бұрын
Please talk slower
@Gocet
@Gocet 4 ай бұрын
This is great!
@user-bd3ib3kd6c
@user-bd3ib3kd6c 7 ай бұрын
i need this ppt plz
@accpemedprn
@accpemedprn 7 ай бұрын
Thanks for your comment! Slides are available for ACCP EMED PRN members. Are you currently a member?